AstraZeneca Q2 profits up 22 pct
AstraZeneca PLC doubled its share buyback program on Thursday after posting strong second quarter results and revealing that a key new drug — its blood thinner Brilinta — has been given a thumbs up by an advisory committee of the U.S.
Read more on AP via Yahoo! Finance
Bayer’s 2nd-Quarter Profit Down 1.3 Percent
Germany’s Bayer posts slight decline in 2nd-quarter net profit to $ 682 million Programming – NET – Component Frameworks – Bayer – Tools
Obese patients lose weight on new Orexigen drug
WASHINGTON (Reuters) – Overweight volunteers who took Orexigen’s experimental drug Contrave, designed to reduce cravings, lost about 13 pounds (6 kg) over a year, U.S. researchers reported on Thursday.
Read more on The Star
Related posts:
- Latest Generic Drugs News
- Latest Generic Drugs News
- Latest Generic Drugs News
- Latest Generic Drugs News
- AstraZeneca Wins Backing on Drug to Rival Plavix and Replace Aging Drugs
Tags: Drugs, Generic, Latest, News